References:
[1] Saposnik G, Barinagarrementeria F, Brown Jr RD, Bushnell CD,
Cucchiara B, Cushman M, Deveber G, Ferro JM, Tsai FY. Diagnosis and
management of cerebral venous thrombosis: a statement for healthcare
professionals from the American Heart Association/American Stroke
Association. Stroke. 2011 Apr;42(4):1158-92.
[2] Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of
cerebral venous thrombosis: a cross-sectional study. Stroke. 2012
Dec;43(12):3375-7.
[3] Ferro JM, Canhao P. Cerebral venous thrombosis: Etiology,
clinical features, and diagnosis. UpToDate [database on the
internet]. Waltham: UpToDate. 2019.
[4] Kreidy R, Irani-Hakime N. Is thrombophilia a major risk factor
for deep vein thrombosis of the lower extremities among Lebanese
patients?. Vascular Health and Risk Management. 2009;5:627.
[5] Siegler JE, Samai A, Albright KC, Boehme AK, Martin-Schild S.
Factoring in factor VIII with acute ischemic stroke. Clinical and
Applied Thrombosis/Hemostasis. 2015 Oct;21(7):597-602.
[6] van Vlijmen EF, Wiewel‐Verschueren S, Monster TB, Meijer K.
Combined oral contraceptives, thrombophilia and the risk of venous
thromboembolism: a systematic review and meta‐analysis. Journal of
Thrombosis and Haemostasis. 2016 Jul;14(7):1393-403
[7] Rosendaal FR, Briet E, Stibbe J, Herpen GV, Leuven JG, Hofman A,
Vandenbroucke JP. Haemophilia protects against ischaemic heart disease:
a study of risk factors. British journal of haematology. 1990
Aug;75(4):525-30.
[8] Audebert H, Planck J, Eisenburg M, Schrezenmeier H, Haberl RL.
Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria.
Journal of neurology. 2005 Nov 1;252(11):1379-86.